Vaginal immunization of cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens

Vaccine

Volumn 16, Issue 5, 1998, Pages 485-492

  Di Fabio, S ^a   Medaglini, D ^b   Rush, C M ^b   Corrias, F ^a   Panzini, G L ^a   Pace, M ^a   Verani, P ^a   Pozzi, G ^b,c   Titti, F ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Mucosal vaccines; Recombinant vaccines; Vaginal immunization

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; INTRAVAGINAL DRUG ADMINISTRATION; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; STREPTOCOCCUS GORDONII;

EID: 17944392846     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)80002-3     Document Type: Article

References (56)

1. 1 Ogra, P.L. and Ogra, S.S. Local antibody response to polio-vaccine in the human female genital tract. J. Immunol 1973, 110, 1307-1311
2. 2 Hanenberg, B., Kendall, D., Amerongen, H.M., Apter, F.M., Kraehenbuhl, J.-P. and Neutra, M.R. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 1994, 62, 15-23
3. 3 Hopkins, S., Kraehenbuhl, J.P. and Schodel, F. et al. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunisation. Infect. Immun. 1995, 63, 3279-3286
4. 4 Lehner, T., Bergmeier, L.A. and Panagiotidi, C. et al. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 1992, 258, 1365-1369
5. 5 Marx, P.A., Compans, R.W. and Gettie, A. et al. Protection against SIV transmission with microencapsulated vaccine. Science 1993, 260, 1323-1327
6. 6 O'Hagan, D.T., Rafferty, D., Wharton, S. and Illum, L. Intravaginal immunisation in sheep using a bioadhesive microsphere antigen delivery system. Vaccine 1993, 11, 660-664
7. 7 Thapar, M.A., Parr, E.L., Bozzola, J.J. and Parr, M.B. Secretory immune responses in the mouse vagina after parenteral or intravaginal immunisation with an immunostimulating complex (ISCOM). Vaccine 1991, 9, 129-133
8. 8 Thapar, M.A., Parr, E.L. and Parr, M.B. The effect of adjuvants on antibody titers in mouse vaginal fluid after pelvic, parenteral, or vaginal immunisation. J. Reproduct. Immunol. 1990, 17, 207-216
9. 9 Thapar, M.A., Parr, E.L. and Parr, M.B. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunisation. Immunology 1990, 70, 121-125
10. 10 McDermott, M.R., Goldsmith, C.S., Rosenthal, K.S. and Brais, L.J. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. J. Infect. Dis. 1989, 159, 460-466
11. 11 Brunham, R.C., Kuo, C.C., Cles, L. and Homes, K.K. Correlation of the host immune response with quantitative recovery of Chlamydia tracomatis from the human endocervix. Infect. Immun. 1983, 39, 1491-1494
12. 12 Cotter, W., Meng, Q., Shen, Z., Zhang, Y., Su, H. and Caldwell, H.D. Protective efficacy of major outer membrane protein-specific immune-globulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect. Immun. 1995, 63, 4704-4714
13. 13 Cone, R.A. and Whaley, K. Monoclonal antibodies for reproductive health: Part I. Preventing sexual transmission of disease and pregnancy with topically applied antibodies. Am. J. Reproduct. Immunol. 1994, 32, 114-131
14. 14 Mestecky, J. The common mucosal immune system and current strategies for induction of immune responses on external secretions. J. Clin. Immunol. 1987, 7, 265-276
15. 15 McDermott, M.R. and Bienenstock, J. Evidence for a common mucosal immunologic system. I. Migration of immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 1979, 122, 1892-1898
16. 16 McDermott, M.R., Clark, D.A. and Bienenstock, J. Evidence for a common immunologic system. II Influence of the oestrus cycle on B immunoblasts migration into genital and intestinal tissues. J. Immunol. 1980, 124, 2536-2539
17. 17 de Haan, A., Renegar, K.B., Small, P.A. and Wilschut, J. Induction of a secretory IgA response in the murine female urogenital tract by immunisation of the lungs with liposome-supplemented viral subunit antigen. Vaccine 1995, 13, 613-616
18. 18 Lehner, T., Panagiotidi, C., Bergmeier, L.A., Ping, T., Brookes, R. and Adams, S.E. A comparison of immune response following oral, vaginal or rectal route of immunisation with SIV antigens in non human primates. Vaccine Res. 1992, 1, 319-330
19. 19 Pal, S., Fielder, T.J., Peterson, E.M. and De La Maza, L.M. Protection against infertility in a Balb/c mouse salpingitis model by intranasal immunisation with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun. 1994, 62, 3354-3362
20. 20 Hanenberg, B., Kendall, D., Amerongen, H.M., Apter, F.M., Kraehenbuhl, J.-P. and Neutra, M.R. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 1994, 62, 15-23
21. 21 Nedrud, J.G., Liang, X., Hague, N. and Lamm, M.E. Combined oral-nasal immunisation protects mice from Sendai virus infection. J. Immunol. 1987, 139, 3484-3492
22. 22 Ogra, P.L. and Karzon, D.T. Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunisation of lower alimentary tract with polio-vaccine. J. Immunol. 1969, 102, 1423-1430
23. 23 Pozzi, G. Streptococcus live vectors of recombinant vaccines. XI Lancefield International Symposium on Streptococci and Streptococcal Diseases, Siena 1990. Abstract: L34, p. 33
24. 24 Pozzi, G., Oggioni, M.R. and Medaglini, D. Recombinant Streptococcus gordonii as a live vehicle for vaccine antigens. In Gram-positive Bacteria as Vaccine Vehicles for Mucosal Immunisation, eds Pozzi G. and Wells J.M. Biotechnology Intelligence Units, Springer-Verlag Berlin and Landes Bioscience Georgetown, p. 35-60, 1997.
25. 25 Medaglini, D., Ricci, S. and Maggi, T. et al. Recombinant Gram-positive bacteria as vehicles of vaccine antigens. Biotechnology Rev. 1997, 3, 297-312
26. 26 Rush, C.M., Mercenier, A. and Pozzi, G. Expression of vaccine antigens in Lactobacillus. In Gram-positive Bacteria as Vaccine Vehicles for Mucosal Immunisation, eds Pozzi G. and Wells J.M. Biotechnology Intelligence Units, Springer-Verlag Berlin and Landes Bioscience Georgetown, p. 107-144, 1997.
27. 27 Pozzi, G., Contorni, M. and Oggioni, M.R. et al. Delivery and expression of a heterologous antigen on the surface of streptococci. Infect. Immun. 1992, 60, 1902-1907
28. 28 Pozzi, G., Oggioni, M.R., Manganelli, R. and Fischetti, V.A. Surface expression of M6 protein in Streptococcus gordonii Challis after transcriptional fusion with chromosomal promoters. Res. Microbiol. 1992, 143, 449-459
29. 29 Pozzi, G., Oggioni, M.R. and Manganelli, R. et al. Recognition by human T helper cells of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. Vaccine 1994, 12, 1071-1076
30. 30 Oggioni, M.R., Medaglini, D., Contorni, M., Cavalieri, F. and Pozzi, G. Expression of fusion proteins in the naturally transformable Streptococcus gordonii (Streptococcus sanguis) Challis. In: DNA Transfer and Gene Expression in Microorganisms (Eds D Balla, E., Berencsi, G. and Szentirmai, A.). Intercept Ltd, Andover, 1993, pp. 235-240
31. 31 Oggioni, M.R. and Pozzi, G. A host-vector system for heterologous gene expression in Streptococcus gordonii. GEne 1996, 169, 85-90
32. 32 Oggioni, M.R., Manganelli, R., Contorni, M., Tommasino, M. and Pozzi, G. Immunisation of mice by oral colonisation with live recombinant commensal streptococci. Vaccine 1995, 13, 775-780
33. 33 Medaglini, D., Pozzi, G., King, T.P. and Fischetti, V.A. Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Sfrepfococcus gordonii after oral colonisation. Proc. Natl. Acad. Sci. USA 1995, 92, 6868-6872
34. 34 Medaglini, D., Rush, C.M., Sestini, P. and Pozzi, G. Commensal bacteria as vehicles for mucosal vaccines against sexually transmitted diseases: vaginal colonisation with recombinant streptococci induces local and systemic antibodies in mice. Vaccine 1997, 15, 1330-1337.
35. 35 Miller, C.J., Alexander, N.J. and Sutjipto, S. et al. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J. Virol. 1989, 63, 4277-4284
36. 36 Miller, C.J. and Gardner, M.B. AIDS and mucosal immunity: usefulness of the SIV macaque model of genital mucosal transmission. J. Acq. Immunodef. Synd. 1991, 4, 1169-1172
37. 37 Spira, I.A., Marx, P.A. and Patterson, B.K. et al. Cellular target of infections and route of viral dissemination after an intra-vaginal inoculation of Simian Immunodeficiency virus into Rhesus macaques. J. Exp. Med. 1996, 183, 215-225
38. 38 Lehener, T., Wang, J. and Cranage, M. et al. Mucosal immunity elicited by targeted iliac lymph node immunisation with a subunit SIV envelope and core vaccine in macaques. Nature Med. 1995, 2, 767-772
39. 39 Lehener, T. and Miller, C.J. Rectal and genital immunisation with SIV/HIV. In: Mucosal Vaccines (Eds Kiyono, H., Ogra, P.L. and McGhee, J.R.), Academic Press, San Diego, 1996, pp. 357-371
40. 40 Oggioni, M.R., Medaglini, D., Romano, L. et al. Expression of the V3 domain of HIV-1 gp120 on the surface of the Gram-positive bacterium Streptococcus gordonii. Submitted
41. 41 Pozzi, G., Musmanno, R.A., Lievens, P.M.-J., Oggioni, M.R., Plevani, P. and Manganelli, R. Methods and parameters for genetic transformation of S. gordonii. Res. Microbiol. 1990, 141, 659-670
42. 42 Tommasino, M., Contorni, M., Scarlato, V., Bugnoli, M., Maundell, K. and Cavalieri, F. Synthesis, phosphorilation, and nuclear localisation of human papillomavirus E7 protein in Schizosaccharomyces pombe. Gene 1990, 93, 265-268
43. 43 Myers, G., Korber, J.A., Berzousky, R.F., Smith, R.F. and Pavlakis, G.N. Human retroviruses and AIDS. A compilation and analysis of nucleic acid and aminoacid sequences. Los Alamos National Laboratory, Los Almos, NM, 1991
44. 44 Curran, J.W., Morgan, W.M., Hardy, A.M., Jaffe, H.W., Darrow, W.W. and Dowdle, W.R. The epidemiology of AIDS: current status and future prospects. Science 1985, 229, 1352-1357
45. 45 European Study Group on Heterosexual Transmission of HIV, Comparison of female to male and male to female transmission of HIV in 563 staple couples. Br. Med. J. 1992, 304, 809
46. 46 Felman, Y.M. Recent developments in sexually transmitted diseases: its heterosexual transmission of HIV a major epidemiologic factor in the spread of AIDS? New York City's experience. Sexually Transmitted Diseases 1990, 46, 29-31
47. 47 Winkelstein, W., Wiley, J.A., Padian, N. and Levy, J. Potential for transmission of AIDS-associated retrovirus from bisexual men in San Francisco to their female sexual contacts. J. Am. Med. Assoc. 1986, 255, 901
48. 48 Cameron, D.W., Simonsen, J.N. and D'Costa, L.J. et al. Female to male transmission of human immunideficiency virus type 1: risk factors for seroversion in men. Lancet 1989, 2, 403-407
49. 49 Belec, L., Georges, A., Steenman, G. and Martin, P. Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J. Infect. Dis. 1989, 160, 385-391
50. 50 Archibald, D.W., Witt, D.J., Craven, D.E., Vogt, M.W., Hirsch, M.S. and Essex, M. Antibodies to human immunodeficiency virus in cervical secretions from women at risk from AIDS. J. Infect. Dis. 1987, 156, 240-241
51. 51 Lu, X.S., Belec, L. and Pilot, J. Anti-gp160 IgG and IgA antibodies associated with a large increase with total IgG in cervicovaginal secretions from human immunodeficiency virus type 1 infected women. J. Infect. Dis. 167, 1189-1192
52. 52 Miller, C., Kang, D. and Marthas, M. et al. Genital secretory immune response to chronic SIV infection: a comparison between intravenously and genitally inoculated rhesus macaques. Clin. Exp. Immunol. 1992, 88, 520-526
53. 53 Crum, P.C., Barber, S. and Roche, J.K. Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis. Clin. Microbiol. Rew. 1991, 4, 270-285
54. 54 Lorincz, A.T., Reid, R., Jenson, A.B., Greeneberg, M.D., Lancaster, W. and Kurnam, R.J. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 1992, 79, 328-337
55. 55 Chen, L., Thomas, E.K., Shiu-Lok, H., Hellstrm, I. and Hellstrm, K.E. Human papillomavirus type 16 nucleoprotein is a tumour rejection antigen. Proc. Natl. Acad. Sci. USA 1991, 88, 110-114
56. 56 Cason, J., Khan, S.A. and Best, J.M. Towards vaccines against human papillomavirus type 16 genital infections. Vaccine 1993, 6, 603-611.